Rapid syphilis testing at family planning visits in Hawai‘i
Official title: Feasibility and Acceptability of Point of Care Rapid Syphilis Testing Among Patients Seeking Family Planning Services in Hawai'i
Run by Queen's Medical Center · NCT07358949 · Data updated 2026-11-12
This study checks if a quick fingerstick syphilis test done during a family planning visit is practical and acceptable for patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 14 Years and up |
| Sex | Women only |
| Enrollment | 70 (estimated) |
| Sponsor | Queen's Medical Center Academic / other |
| Locations | 1 site (Honolulu, Hawaii) |
| Status | Recruiting |
| Started | July 20, 2026 |
| Main results expected | August 1, 2027 |
| Study ends | December 2027 |
| Registry record updated | September 16, 2026 |
| Trial ID | NCT07358949 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are sexually active adults aged 14+ seeking contraception or abortion services at Queen’s Medical Center who speak English and have capacity for informed consent.
✕Probably not a fit
Patients who do not want testing or do not meet eligibility criteria may not benefit from rapid testing.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This nonrandomized feasibility study tests the Syphilis Health Check rapid, point-of-care test at a university-affiliated Hawaii family planning clinic. Clinicians will perform the fingerstick test during abortion or contraception visits, with positive results confirmed by laboratory testing. The study aims to see whether offering rapid testing is feasible for staff and acceptable to patients, and to estimate how many participants are needed for future work. Enrollment targets 50–75 sexually active adults ages 14 and older who seek contraception or abortion services in Hawai‘i.
Why it matters
Potential benefit: If successful, patients can learn their syphilis status within the same visit and start treatment promptly if needed.
How similar studies have gone: Previous rapid, point-of-care syphilis tests have shown feasibility in other settings, but this Hawaii study is a focused feasibility assessment in a family planning clinic.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 14 years or older * Seeking contraception or abortion services * Sexually active (engages in any form of sexual activity with another person) * Denies history of syphilis infection * Can speak and read English * Displays capacity for informed consent Exclusion Criteria: * Confirmed history (by patient report or medical records) of syphilis * Home address outside Hawai'i * Currently incarcerated Number of Subjects: Recommendations for sample size in pilot studies range from 70 to 100 patients.28 Given this is a nonrandomized feasibility study with no comparator (i.e., to a control or to serological testing), we aim to enroll 50 to 75 participants to support analysis for correlation between variables while being able to achieve relatively small confidence intervals. This number takes into account the practical considerations of study personnel resources and in-person patient volume in our clinic. All patients eligible for the rapid syphilis testing will be approached for study participation.
Where it's running
-
Queen's Medical Center, 1004 Clinic POB1
Honolulu, Hawaii, United States Recruiting
Study contacts
- Study coordinator: Elaine Chan, MD
- Email: echan99@hawaii.edu
- Phone: 415-596-1812
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
TruPlex HIV/HepB/Syphilis Rapid Test performance and usability in real-world settings
This study tests how well the TruPlex rapid test detects HIV, hepatitis B, and syphilis using fingerstick and other blood samples, and whether trained operators find the test easy to use at point-of-care sites.
-
TruPlex rapid test for HIV, Hepatitis B, and syphilis performance and usability
This project will test whether the TruPlex rapid test can accurately detect HIV, hepatitis B, and syphilis when used by trained healthcare workers on adults getting tested for these infections.
-
Doxycycline after sex to prevent gonorrhea, chlamydia, and syphilis in MSM in Bangkok
This research tests whether taking doxycycline after sex can prevent gonorrhea, chlamydia, and syphilis in men who have sex with men in Bangkok.
-
New ALPCO blood tests to detect syphilis antibodies
This will test two ALPCO blood tests that look for treponemal and non-treponemal antibodies in people screened for or suspected of having syphilis, including pregnant and HIV-positive individuals.
-
Multiplo HIV and syphilis self-test for adults
This project will see if adults seeking HIV or syphilis testing can correctly use the Multiplo HIV/syphilis self-test to get accurate results.
-
Using lidocaine to reduce pain from benzathine penicillin injections for syphilis treatment
This study is testing if adding lidocaine to syphilis treatment injections can help reduce the pain patients feel during and after the shot.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.